Janssen slammed with $70 million verdict in Risperdal lawsuit

A Philadelphia jury has found Johnson & Johnson and its Janssen Pharmaceuticals unit liable for failing to warn consumers that its antipsychotic drug Risperdal can cause boys and young men to develop female breasts – a condition known as gynecomastia.

On July 1st, 17-year-old Andrew Yaunt was awarded $70 million in compensatory damages for the injuries he suffered while taking the drug. This marks the largest award yet in Risperdal litigation.

According to the lawsuit, Janssen is accused of manipulating studies that highlight the link between Risperdal and gynecomastia.

This was the fifth Risperdal lawsuit to be tried in Philadelphia, and by far the largest verdict. Earlier verdicts range from $500,000 to upwards of $2.2 million.

Originally approved for schizophrenia and bipolar disorder, Risperdal was targeted to seniors with dementia and children with behavioural disorders, a much more lucrative market.

If you suffered ill effects or if a loved one has died after taking a prescription medication, you may have a valid injury claim against the manufacturer, pharmacy or prescribing physician depending on the facts and circumstances surrounding your case. It is in your best interests to contact a skilled attorney as soon as possible. Here at The Carlson Law Firm we have a team of attorneys, nurses and investigators who are ready to assist. Contact us today for your free consultation. We serve injured clients nationwide.

Facebooktwittergoogle_pluspinterestlinkedinmail

Other Blogs


Back to Top